400
Participants
Start Date
May 15, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
September 30, 2027
Sucrose Iron，subcutaneous recombinant human erythropoietin，intravenous vitamin C
Patients in the experimental group will receive a combination therapy consisting of intravenous sucrose iron (200 mg), subcutaneous recombinant human erythropoietin (150 IU/kg), and intravenous vitamin C (2 g), administered once daily for three consecutive days within the week prior to surgery.
Routine perioperative management
Routine perioperative management based on clinical judgment, including observation, monitoring, and standard nursing practices.
RECRUITING
Department of Anesthesiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
First Affiliated Hospital of Chongqing Medical University
OTHER
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
First Affiliated Hospital of Wenzhou Medical University
OTHER
Zhejiang Provincial People's Hospital
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER